Mankind Pharma Ltd. Press Release Aug 20 2026

About this update from Mankind Pharma Ltd.

Mankind Pharma Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Mankind Pharma Enters into Exclusive In-Licensing Agreement for Insulin Degludec and Insulin Degludec + Aspart Combination for India". View Attachment

View stock analysis, news, and events for Mankind Pharma Ltd.